• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.29 Up 0.07(3.15%) 4:00PM EST
    |After Hours : 2.29 Up 0.00 (0.01%) 4:42PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   5,750  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   5,750  
    Operating Expenses
    Research Development16,151  20,063  16,869  18,046  
    Selling General and Administrative4,889  5,393  5,516  4,648  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (21,040) (25,456) (22,385) (16,944)
    Income from Continuing Operations
    Total Other Income/Expenses Net98  65  82  83  
    Earnings Before Interest And Taxes(20,942)(25,391)(22,303)(16,861)
    Interest Expense -   -   -   -  
    Income Before Tax(20,942)(25,391)(22,303)(16,861)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(20,942)(25,391)(22,303)(16,861)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (20,942) (25,391) (22,303) (16,861)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (20,942) (25,391) (22,303) (16,861)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.